Strong variability of Di(2-ethylhexyl)phthalate (DEHP) plasmatic rate in infants and children undergoing 12-hour cyclic parenteral nutrition

Journal of Parenteral and Enteral Nutrition

Volumn 37, Issue 2, 2013, Pages 229-235

  Kambia, Nicolas ^a   Dine, Thierry ^a   Gressier, Bernard ^a   Luyckx, Michel ^a   Brunet, Claude ^a   Guimber, Dominique ^b   Turck, Dominique ^b   Gottrand, Frederic ^b   Michaud, Laurent ^b  

^a Cité scientifique   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

cyclic parenteral nutrition; DEHP; exposure; infants and children; potential risks

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ADOLESCENT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CHILD NUTRITION; CHILD SAFETY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; EMULSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; INFANT NUTRITION; MALE; MEASUREMENT; NEWBORN; NUTRITIONAL ASSESSMENT; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETHYLHEXYL PHTHALATE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFANT; MALE; PARENTERAL NUTRITION; POLYVINYL CHLORIDE;

EID: 84873618070     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112450914     Document Type: Article

References (27)

1. Rael LT, Bar-Or R, Ambruso DR, et al. Phthalate esters used as plasticizers in packed red blood cell storage bags may lead to progressive toxin exposure and the release of pro-inflammatory cytokines. Oxid Med Cell Longev. 2009 ; 2 (3). 166-171
2. Shea KM. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics. 2003 ; 111: 1467-1474 (Pubitemid 36682291)
3. European Commission: Health & Consumer Protection Directorate-General. Medical devices containing DEHP plasticised PVC; neonates and other groups possibly at risk from DEHP toxicity. September2002. http://ec.europa.eu/food/fs/sc/scmp/out43-en.pdf
4. Latini G, Ferri M, Chiellini F. Materials degradation in PVC medical devices, DEHP leaching and neonatal outcomes. Curr Med Chem. 2010 ; 17: 2979-2989
5. Rais-Bahrami K, Nunez S, Revenis ME, Luban NLC, Short BL. Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environ Health Perspect. 2004 ; 112: 1339-1340 (Pubitemid 39294975)
6. Latini G. Monitoring phthalate exposure in humans. Clin Chim Acta. 2005 ; 361: 20-29 (Pubitemid 41382607)
7. Wittassek M, Martin Koch H, Angerer J, Brüning T. Assessing exposure to phthalates: the human biomonitoring approach. Mol Nutr Food Res. 2011 ; 55: 7-31
8. Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril. 2008 ; 89: 33-38
9. Swan SH. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res. 2008 ; 108: 177-184
10. Kambia N, Dine T, Gressier B, et al. Correlation between exposure to phthalates and concentrations of malondialdehyde in infants and children undergoing cyclic parenteral nutrition. JPEN J Parenter Enteral Nutr. 2011 ; 35: 395-401
11. Genay S, Luciani C, Décaudin B, et al. Experimental study on infusion devices containing polyvinyl chloride: to what extent are they di(2-ethylhexyl)phthalate-free?. Int J Pharm. 2011 ; 412: 47-51
12. Kambia K, Dine T, Gressier B, et al. Evaluation of childhood exposure to di(2-ethylhexyl) phthalate from perfusion kits during long-term parenteral nutrition. Int J Pharm. 2003 ; 262: 83-91 (Pubitemid 36966696)
13. Bagel S, Dessaigne B, Bourdeaux D, et al. Influence of lipid type on bis (2-ethylhexyl) phthalate (DEHP) leaching from infusion line sets in parenteral nutrition. JPEN J Parenter Enteral Nutr. 2011 ; 35: 770-775
14. Steiner I, Scharf L, Fiala F, Washüttl J. Migration of di-(2-ethylhexyl) phthalate from PVC child articles into saliva and saliva simulant. Food Addit Contam. 1998 ; 15: 812-817 (Pubitemid 28438706)
15. Center for Devices and Radiological Health, U.S. Food and Drug Administration. Safety Assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. http://www.fda.gov/downloads/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/UCM080457.pdf
16. Von Rettberg H, Hannman T, Subotic U, et al. Use of di(2-Ethylhexyl) phthalate-containing infusion systems increases the risk for cholestasis. Pediatrics. 2009 ; 124: 710-716
17. Park JD, Habeebu SS, Klaassen CD. Testicular toxicity of di(2-ethylhexyl)phthalate in young Sprague-Dawley rats. Toxicology. 2002 ; 171: 105-115 (Pubitemid 34142485)
18. Tanaka T. Reproductive and neurobehavioural toxicity study of bis(2-ethylhexyl) phthalate (DEHP) administered to mice in the diet. Food Chem Toxicol. 2002 ; 40: 1499-1506 (Pubitemid 35245212)
19. Qiao L, Zheng L, Cai D. Study on the di-n-butyl phthalate and di(2-ethylhexyl) phthalate level of girl serum related with precocious puberty in Shanghai [in Chinese]. Wei Sheng Yan Jiu. 2007 ; 36: 93-95
20. Cobellis L, Latini G, DeFelice C, et al. High plasma concentrations of di(2-ethylhexyl) phthalate in women with endometriosis. Hum Reprod. 2003 ; 18: 1512-1515 (Pubitemid 36840962)
21. Reddy BS, Rozati R, Reddy S, Kodampur S, Reddy P, Reddy R. High plasma concentrations of polychlorinated biphenyls and phthalate esters in women with endometriosis: a prospective case control study. Fertil Steril. 2006 ; 85: 775-779 (Pubitemid 43261586)
22. Reddy BS, Rozati R, Reddy BV, Raman NV. Association of phthalate esters with endometriosis in Indian women. BJOG. 2006 ; 113: 515-520
23. Durmaz E, N., Özmert E, Erkekoglu P, et al. Plasma phthalate levels in pubertal gynecomastia. Pediatrics. 2010 ; 125: 122-129
24. Grun F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord. 2007 ; 8: 161-171 (Pubitemid 47434649)
25. Office of Environmental Health Hazard Assessment. Toxicological profile for di(2-ethylhexyl) phthalate (DEHP). September2009. http://www.opc.ca.gov/ webmaster/ftp/project-pages/MarineDebris-OEHHA-ToxProfiles/DEHP%20Final.pdf
26. Directive, 2007/47/EC of the European parliament and of the Council of 5 September amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market (OJEU 21.09.2007). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:247:0021:0055: en:PDF
27. Bagel S, Décaudin B, Neuville S, et al. Phthalates in medical devices for parenteral and enteral nutrition. Nutr Clin Metab. 2011 ; 25: 15-23